NCT03912220View on ClinicalTrials.gov

Evaluation of Nicotinamide Riboside in Prevention of Small Fiber Axon Degeneration and Promotion of Nerve Regeneration

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

May 1, 2023

Study Completion Date

May 30, 2023

Conditions
Small Fiber Neuropathy
Interventions
DRUG

Nicotinamide riboside

The experimental arm will investigate the effects of nicotinamide riboside on nerve degeneration and regeneration.

DRUG

Placebo Oral Tablet

Placebo drug that looks like the experimental drug, nicotinamide riboside tablets.

Trial Locations (1)

21205

Johns Hopkins Hospital, Baltimore

All Listed Sponsors
collaborator

Adelson Medical Research Foundation

UNKNOWN

lead

Johns Hopkins University

OTHER

NCT03912220 - Evaluation of Nicotinamide Riboside in Prevention of Small Fiber Axon Degeneration and Promotion of Nerve Regeneration | Biotech Hunter | Biotech Hunter